The Valley Desk

NCT04211337 · Interventional trial

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

Overall registry status Active not recruiting

Phase 3

Conditions Medullary Thyroid Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov